Advanced Search
ORIGINAL ARTICLES  
CMH 2000 September;6:301-310.
Published online 2000 January 01.
Copyright © 2000 The Korean Association for the Study of the Liver
  |  Abstract   |  PDF Links PDF Links   |   Download Citation
Novel Maintenance Therapy with Lamivudine in Patients with Chronic Active Viral Hepatitis B
Sung Pyo Hong, M.D., Chang Il Kwon, M.D., June Sung Lee, M.D., Kyung Chul Kim, M.D., Sung Kyu Hwang, M.D., Pil Won Park, M.D., Gyu Sung Rim, M.D. and Sehyun Kim, Ph.D.1
Department of Internal Medicine and Preventive Medicine1, Pundang CHA Hospital,
Pochon CHA University College of Medicine, Sungnam, Korea
ABSTRACT
Background/Aims: This study was conducted to determine the effect of novel long-term maintenance treatment with lamivudine by gradual lengthening of the medication interval in patients with chronic active viral hepatitis B. Method: All patients were non-responder, relapsed or intolerable patients to previous interferon therapy. Patients were divided into a drug-interval changing study and a daily continual medication control group. Drug-interval changing protocol with gradual lengthening of the medication interval after conversion to undetectable HBV-DNA in serum and reduction of serum aminotransferase to normal level was monitored monthly. Results: Before treatment, 15 patients of the drug-interval change group and 11 patients of the daily medication group were similar in laboratory and pathologic findings. Mean follow-up periods were 12.8 moths and 11.4 months respectively. HBeAg seroconversion rate was higher in patients in the daily medication group (86.7% vs. 40.0%, p<0.05). The odds of loss of HBeAg, development of anti-HBe, and suppression of HBV-DNA are about 11 times, 7 times, and 8 times higher in the drug-interval change group compared with the daily medication group, respectively (p<0.05). Conclusion: Drug-interval lengthening method was effective in long-term suppression of viral replication with low cost.
Keywords: Hepatitis/Viral/Chronic viral hepatitis B, Lamivudine, Maintenance therapy
Don't forget to sign up for journal e-mail alerts so you can keep up to date with all the articles as they are published.
e-submission
CMH
  
vol: Issue: Page:
  
Author's home
Reviewer's home
Editor's home
The Korean Association for the Study of the Liver
KoMCI
PubMed
PubMed Central
Sypapse
KoreaMed
Register for e-submission
Register here to access the e-submission system of CMH for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the CMH e-submission management system at http://submit.e-cmh.org, read the Instructions for Authors, and log into the CMH e-submission system. For assistance with manuscript submission, please contact: kasl@kams.or.kr.
Free archive
Anyone may access any past or current articles without logging in.
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero{MapoTrapalace , Dowha-dong}, Mapo-gu, Seoul, 121-784, Korea
TEL : +82-2-703-0051    FAX : +82-2-703-0071   E-mail : kasl@kams.or.kr
Copyright © By The Korean Association for the Study of the Liver. All right reserved.